Related Experiment Videos
Genetic pathways in colorectal and other cancers
M Ilyas1, J Straub, I P Tomlinson
1Cancer and Immunogenetics Laboratory, Imperial Cancer Research Fund, John Radcliffe Hospital, Headington, Oxford, U.K. ilyas@uropa.lif.icnet.uk
European Journal of Cancer (Oxford, England : 1990)
|March 11, 2000
Summary
Cancer progression involves genetic changes driving aberrant cell behavior. This review examines colorectal cancer (CRC) as a model for multistep carcinogenesis, detailing genetic pathways and their functional impacts for improved therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancer cells exhibit abnormal behaviors like uncontrolled growth, invasion, and metastasis.
- These malignant characteristics are fundamentally linked to underlying genetic alterations and their functional consequences.
- Colorectal cancer (CRC) serves as a key model for understanding multistep carcinogenesis.
Purpose of the Study:
- To review the genetic basis of cancer cell behavior.
- To explore the concept of somatic evolution in tumorigenesis.
- To detail the genetic pathways and molecular mechanisms involved in colorectal cancer development.
Main Methods:
- Review of existing literature on cancer genetics and colorectal carcinogenesis.
- Analysis of genetic mutations and their functional sequelae in CRC.
- Examination of factors influencing the selection of genetic pathways in tumor development.
Main Results:
- Cancers develop through a process of somatic evolution, leading to preferred genetic pathways.
- Specific genetic mutations and their functional impacts in colorectal cancer pathways are identified.
- Factors influencing the progression and choice of these genetic pathways are discussed.
Conclusions:
- Understanding the genetic pathways of colorectal cancer is crucial for elucidating its natural history.
- Further research into these pathways can lead to the development of more effective therapeutic strategies for CRC.
- The genetic model of cancer development provides a framework for studying other cancer types.